GB2413282B - DNA Viral Infections - Google Patents

DNA Viral Infections

Info

Publication number
GB2413282B
GB2413282B GB0409102A GB0409102A GB2413282B GB 2413282 B GB2413282 B GB 2413282B GB 0409102 A GB0409102 A GB 0409102A GB 0409102 A GB0409102 A GB 0409102A GB 2413282 B GB2413282 B GB 2413282B
Authority
GB
United Kingdom
Prior art keywords
viral infections
dna viral
eye
ethanol
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0409102A
Other languages
English (en)
Other versions
GB0409102D0 (en
GB2413282A (en
Inventor
Christopher Edward Hartley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henderson Morley PLC
Original Assignee
Henderson Morley PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henderson Morley PLC filed Critical Henderson Morley PLC
Priority to GB0409102A priority Critical patent/GB2413282B/en
Publication of GB0409102D0 publication Critical patent/GB0409102D0/en
Priority to MXPA06012290A priority patent/MXPA06012290A/es
Priority to US11/568,144 priority patent/US20070219142A1/en
Priority to CA002563744A priority patent/CA2563744A1/en
Priority to JP2007508979A priority patent/JP2007533721A/ja
Priority to EP05738246A priority patent/EP1742638B1/de
Priority to PCT/GB2005/001570 priority patent/WO2005102351A1/en
Priority to AT05738246T priority patent/ATE536876T1/de
Publication of GB2413282A publication Critical patent/GB2413282A/en
Application granted granted Critical
Publication of GB2413282B publication Critical patent/GB2413282B/en
Priority to US12/701,756 priority patent/US20100137232A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0409102A 2004-04-23 2004-04-23 DNA Viral Infections Expired - Fee Related GB2413282B (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0409102A GB2413282B (en) 2004-04-23 2004-04-23 DNA Viral Infections
PCT/GB2005/001570 WO2005102351A1 (en) 2004-04-23 2005-04-25 Composition comprising a diuretic and/or cardiac glycoside for the treatment of dna viral infections of the eye
US11/568,144 US20070219142A1 (en) 2004-04-23 2005-04-25 Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye
CA002563744A CA2563744A1 (en) 2004-04-23 2005-04-25 Composition comprising a diuretic and/or cardiac glycoside for the treatment of dna viral infections of the eye
JP2007508979A JP2007533721A (ja) 2004-04-23 2005-04-25 目のｄｎａウイルス感染症の治療用の利尿および／または強心配糖体を含む組成物
EP05738246A EP1742638B1 (de) 2004-04-23 2005-04-25 Zusammensetzung mit einem diuretikum und herzglykosid zur behandlung von dna-virusinfektionen des auges
MXPA06012290A MXPA06012290A (es) 2004-04-23 2005-04-25 Composicion que comprende un diuretico y/o glicosido cardiaco para el tratamiento de infecciones del ojo por adn viral.
AT05738246T ATE536876T1 (de) 2004-04-23 2005-04-25 Zusammensetzung mit einem diuretikum und herzglykosid zur behandlung von dna- virusinfektionen des auges
US12/701,756 US20100137232A1 (en) 2004-04-23 2010-02-08 Composition comprising a diuretic and a cardiac glycoside for the treatment of dna viral infections of the eye

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0409102A GB2413282B (en) 2004-04-23 2004-04-23 DNA Viral Infections

Publications (3)

Publication Number Publication Date
GB0409102D0 GB0409102D0 (en) 2004-05-26
GB2413282A GB2413282A (en) 2005-10-26
GB2413282B true GB2413282B (en) 2009-01-14

Family

ID=32344297

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0409102A Expired - Fee Related GB2413282B (en) 2004-04-23 2004-04-23 DNA Viral Infections

Country Status (8)

Country Link
US (2) US20070219142A1 (de)
EP (1) EP1742638B1 (de)
JP (1) JP2007533721A (de)
AT (1) ATE536876T1 (de)
CA (1) CA2563744A1 (de)
GB (1) GB2413282B (de)
MX (1) MXPA06012290A (de)
WO (1) WO2005102351A1 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
WO2001049242A2 (en) * 1999-12-30 2001-07-12 Henderson Morley Research And Development Limited Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside
US20030040484A1 (en) * 1998-11-06 2003-02-27 Perez Alfonzo T. Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
JPS6127917A (ja) * 1984-07-16 1986-02-07 Kao Corp 水溶性点眼組成物
US5789435A (en) * 1995-05-22 1998-08-04 Advanced Research And Technology Institute Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight
JPH10152438A (ja) * 1996-11-22 1998-06-09 Takeda Chem Ind Ltd １−アザキサントン誘導体またはその塩の安定化方法および１−アザキサントン誘導体含有組成物
EP1242096B1 (de) * 1999-12-30 2005-10-12 Henderson Morley Research and Development Limited Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
US20060122174A1 (en) * 2001-09-21 2006-06-08 Henderson Morley Research & Development Limited Antiviral treatment
CN1389206A (zh) * 2002-07-08 2003-01-08 南京医科大学第一附属医院 一种抗白内障眼药和角膜渗透促进剂氮酮的眼科应用
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
CN100405658C (zh) * 2004-07-23 2008-07-23 日本无公害电池研究所 电池用镍极及使用该镍极的碱性蓄电池

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
US20030040484A1 (en) * 1998-11-06 2003-02-27 Perez Alfonzo T. Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
WO2001049242A2 (en) * 1999-12-30 2001-07-12 Henderson Morley Research And Development Limited Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside

Also Published As

Publication number Publication date
GB0409102D0 (en) 2004-05-26
EP1742638B1 (de) 2011-12-14
US20070219142A1 (en) 2007-09-20
CA2563744A1 (en) 2005-11-03
WO2005102351A1 (en) 2005-11-03
GB2413282A (en) 2005-10-26
MXPA06012290A (es) 2007-04-12
JP2007533721A (ja) 2007-11-22
EP1742638A1 (de) 2007-01-17
US20100137232A1 (en) 2010-06-03
ATE536876T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
MX2010004549A (es) Composiciones y métodos bacteriostáticos o bactericidas.
EA201000515A1 (ru) Активаторы глюкокиназы
EP2530157A3 (de) Oligomerverbindungen und Zusammensetzungen zur Verwendung bei der Modulation kleiner nichtkodierender RNAs
HRP20070435A2 (en) Tricyclic-nucleoside compounds for treating viral infections
WO2006073890A3 (en) Use of glp-1 and agonists thereof to prevent cardiac myocyte apoptosis
MX2010007295A (es) Composiciones acuosas estables de ciclosporina.
TW200606162A (en) Pyrazolopyridine derivatives
WO2007081974A3 (en) Viral hepatitis treatment
BRPI0814737A2 (pt) Composição, métodos para reduzir, retardar ou de um outro modo inibir o crescimento e/ou replicação de hcv, para prevenir a infecção de uma célula exposta a hcv, para tratar terapeuticamente ou profilaticamente um paciente exposto ou infectado com hcv, e para tratar hepatite c, e, uso de uma composição.
PL381801A1 (pl) Pochodne mocznika, kompozycje zawierające pochodne mocznika oraz zastosowanie pochodnych mocznika do wytwarzania leku do leczenia skurczowej niewydolności serca
EP2182063A3 (de) Modulierung von EIF4E-Expression
BRPI0515478A (pt) derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
ATE501718T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von manie und bipolaren störungen
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
ATE457729T1 (de) Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie
TW200728295A (en) Benzochromene derivatives
CO6290689A2 (es) Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica
ATE431447T1 (de) Membran-elektrolysereaktorensystem mit vier kammern
TR200401363T4 (tr) DNA viral enfeksiyonlarının tedavisi
GB2413282B (en) DNA Viral Infections
GB0505689D0 (en) Improvements in or relating to the regeneration of water treatment substrates
EA201000330A1 (ru) Способ повышения значения ph кислых водоемов
CN102550451B (zh) 一种珍珠细胞活性液及其在珍珠养殖中的应用
CN102524121A (zh) 一种珍珠细胞染色剂及其在珍珠养殖中的应用

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20110423